| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Journal of Clinical Microbiology, November 2006, p. 4204-4207, Vol. 44, No. 11
0095-1137/06/$08.00+0 doi:10.1128/JCM.00918-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Université Paris VII, UFR Médicale; EA 3105, Laboratoire d'Études de Génétique Bactérienne dans les Infections de l'Enfant; and Assistance Publique-Hôpitaux de Paris, Service de Microbiologie, Hôpital Robert Debré, Paris, France,1 Université Paris VI, Faculté de Médecine Pierre et Marie Curie, and UPRES EA 2392, Laboratoire de Bactériologie, Paris, France2
Received 2 May 2006/ Returned for modification 12 June 2006/ Accepted 29 August 2006
We report on the first detection of an AmpC-type Ambler class C 1 (ACC-1) ß-lactamase in Citrobacter freundi isolated from a patient also harboring ACC-1-producing Escherichia coli and Klebsiella pneumoniae. We propose a simple cefoxitin-based double-disk synergy test (DDST) for the specific detection of ACC-1 in members of the family Enterobacteriaceae, including natural AmpC producers, in association with a cloxacillin-based DDST as a first-line AmpC-type ß-lactamase screening test.
Published ahead of print on 13 September 2006.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|